If regulated and employed correctly, this plan could generate a wider consumer market for the EpiPens, and consumers would not be barred from purchasing the item due to a high price tag. In this system, if a person has low income, the price of the EpiPen would be relatively low. A person with moderate reactions and excessively high income would pay a relatively high price. Then everyone else would have a to pay a median price dependent on the evaluation of their health needs. Every few years when a new pen is bought, each person must be reevaluated by a doctor to ensure that they are still in the same position medically along that sliding scale. Then everyone who needs an EpiPen can get access to them. This evaluation-based distribution is similar to Oregon’s system for its Medicaid patients: “a long list of medical procedures, ranked in terms of their cost/benefit ratio, determines the reimbursement policy” (Jonsen). Nonetheless, this type of system is easily corruptible because it can be subjective; the overall price of the pens can be skewed for or against a person depending on a multitude of different factors, such as who might be ranking that person’s need, or, in Oregon’s case, their cost/benefit
If regulated and employed correctly, this plan could generate a wider consumer market for the EpiPens, and consumers would not be barred from purchasing the item due to a high price tag. In this system, if a person has low income, the price of the EpiPen would be relatively low. A person with moderate reactions and excessively high income would pay a relatively high price. Then everyone else would have a to pay a median price dependent on the evaluation of their health needs. Every few years when a new pen is bought, each person must be reevaluated by a doctor to ensure that they are still in the same position medically along that sliding scale. Then everyone who needs an EpiPen can get access to them. This evaluation-based distribution is similar to Oregon’s system for its Medicaid patients: “a long list of medical procedures, ranked in terms of their cost/benefit ratio, determines the reimbursement policy” (Jonsen). Nonetheless, this type of system is easily corruptible because it can be subjective; the overall price of the pens can be skewed for or against a person depending on a multitude of different factors, such as who might be ranking that person’s need, or, in Oregon’s case, their cost/benefit